This page tracks future news about treatments in development for sensorineural hearing loss (SNHL). What’s on the horizon? What’s happening soon? What to expect? Future topics include GW-HTL2, PIPE-505, FX-322, SENS-401, and more.
- Pipeline Therapeutics Announces Topline Results from Phase 1/2a Clinical Trial of PIPE-505 in Sensorineural Hearing Loss Sep 15, 2021
- Frequency Therapeutics Completes Phase 1b Study of FX-322 in Adults with Severe Sensorineural Hearing Loss Sep 1, 2021
- Gateway Biotechnology Provides Update on GW-HLT2 for Hearing Loss Aug 19, 2021
- Sensorion Reports Primary Completion of Phase 2 Study of SENS 401 for Severe Sensorineural Hearing Loss Aug 9, 2021